FILE - COVID-19 antigen home tests indicating a positive result are photographed in New York, April 5, 2023. A study was ...

SEATTLE, WA / ACCESSWIRE / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's ...

The fluent French speaker was teaching English in China when she wrote home asking for some anti-malaria pills. But after two doses she told her family in Swansea that the Lariam had made her ill ...

With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

Results from the malaria vaccine trial indicate that GA2 immunization provides significant protection, paving the way for ...

Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

"This breakthrough is a big step forward in developing new malaria treatments," Yu said. "By focusing on PfNCR1, scientists could develop drugs that the parasite finds difficult to develop ...

Charting, Price Performance, News & Related Contracts.